Free Trial
→ DeFi Coin on Verge of Breakout! (From Crypto 101 Media) (Ad) Free FTXH Stock Alerts

First Trust Nasdaq Pharmaceuticals ETF (FTXH) Short Interest Ratio & Short Volume

$27.50 +0.24 (+0.88%)
(As of 12/17/2024 ET)
Compare

First Trust Nasdaq Pharmaceuticals ETF Short Interest Data

First Trust Nasdaq Pharmaceuticals ETF (FTXH) has a short interest of 200 shares. This marks a -81.82% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 5,056 shares to cover all short positions.

Current Short Interest
200 shares
Previous Short Interest
1,100 shares
Change Vs. Previous Month
-81.82%
Dollar Volume Sold Short
$5,672.00
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
600,000 shares
Percentage of Shares Shorted
0.03%
Today's Trading Volume
1,684 shares
Average Trading Volume
5,056 shares
Today's Volume Vs. Average
33%
Short Selling First Trust Nasdaq Pharmaceuticals ETF?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for First Trust Nasdaq Pharmaceuticals ETF and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

FTXH Short Interest Over Time

FTXH Days to Cover Over Time

FTXH Percentage of Float Shorted Over Time

First Trust Nasdaq Pharmaceuticals ETF Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/2024200 shares $5,672.00 -81.8%N/A0.1 $28.36
11/15/20241,100 shares $29,810.00 -62.1%N/A0.3 $27.10
10/31/20242,900 shares $81,983.00 +93.3%N/A0.8 $28.27
10/15/20241,500 shares $43,350.00 +200.0%N/A0.4 $28.90
9/30/2024500 shares $14,418.45 +66.7%N/A0.1 $28.84
9/15/2024300 shares $8,757.00 -66.7%N/A0.1 $29.19
8/31/2024900 shares $26,689.86 +200.0%N/A0.2 $29.66
8/15/2024300 shares $8,577.00 -85.0%N/A0.1 $28.59
7/31/20242,000 shares $57,102.40 +25.0%N/A0.4 $28.55
7/15/20241,600 shares $44,832.00 No ChangeN/A0.3 $28.02
2/15/20241,000 shares $27,800.30 -66.7%N/A0.1 $27.80
1/31/20243,000 shares $80,910.00 -44.4%N/A0.4 $26.97
1/15/20245,400 shares $147,366.00 +500.0%N/A0.7 $27.29
12/31/2023900 shares $23,953.50 -35.7%N/A0.1 $26.62
12/15/20231,400 shares $36,652.00 +1,300.0%N/A0.2 $26.18
11/30/2023100 shares $2,498.00 -66.7%N/A0 $24.98
11/15/2023300 shares $7,368.00 +200.0%N/A0 $24.56
10/31/2023100 shares $2,404.00 -66.7%N/A0 $24.04
10/15/2023300 shares $7,683.00 +50.0%N/A0 $25.61
9/30/2023200 shares $5,113.52 -89.5%N/A0 $25.57
9/15/20231,900 shares $50,160.00 -77.1%N/A0.2 $26.40
8/31/20238,300 shares $223,021.00 +8,200.0%N/A0.6 $26.87
8/15/2023100 shares $2,705.00 -66.7%N/A0 $27.05
7/31/2023300 shares $7,960.89 -66.7%N/A0 $26.54
7/15/2023900 shares $23,418.00 -76.3%N/A0.1 $26.02
6/30/20233,800 shares $99,522.00 -28.3%N/A0.3 $26.19
6/15/20235,300 shares $140,821.00 -15.9%N/A0.6 $26.57
5/31/20236,300 shares $161,028.00 +6,200.0%N/A0.5 $25.56
5/15/2023100 shares $2,662.00 -66.7%N/A0 $26.62
4/30/2023300 shares $7,979.88 -25.0%N/A0 $26.60
4/15/2023400 shares $10,760.00 -20.0%N/A0 $26.90
3/31/2023500 shares $13,049.20 +400.0%N/A0 $26.10
3/15/2023100 shares $2,552.87 -99.0%N/A0 $25.53
2/28/20239,500 shares $249,850.00 -65.5%N/A0.7 $26.30
2/15/202327,500 shares $749,289.75 +19.6%N/A2.4 $27.25
1/31/202323,000 shares $633,190.00 -9.1%N/A2.1 $27.53
1/15/202325,300 shares $707,663.77 +94.6%N/A2.1 $27.97
12/30/202213,000 shares $356,590.00 -41.2%N/A0.9 $27.43
12/15/202222,100 shares $612,612.00 -29.2%N/A1.7 $27.72
11/30/202231,200 shares $874,536.00 +339.4%N/A2.4 $28.03
DeFi Coin on Verge of Breakout! (Ad)

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!
11/15/20227,100 shares $190,990.00 +153.6%N/A0.6 $26.90
10/31/20222,800 shares $74,032.00 +64.7%N/A0.2 $26.44
10/15/20221,700 shares $41,752.00 No ChangeN/A0.1 $24.56
9/30/20223,700 shares $88,948.00 -28.9%N/A0.2 $24.04
9/15/20225,200 shares $130,052.00 -27.8%N/A0.1 $25.01
8/31/20227,200 shares $179,136.00 -56.9%N/A0.1 $24.88
8/15/202216,700 shares $445,222.00 +18.4%N/A0.3 $26.66
7/31/202214,100 shares $373,509.00 +93.2%N/A0.3 $26.49
7/15/20227,300 shares $194,764.00 No ChangeN/A0.2 $26.68
2/15/20226,100 shares $156,831.00 -10.3%N/A2 $25.71
1/31/20226,800 shares $175,304.00 -13.9%N/A2.2 $25.78
1/15/20227,900 shares $203,425.00 -16.8%N/A2.5 $25.75
12/31/20219,500 shares $257,070.00 +4.4%N/A3.4 $27.06
12/15/20219,100 shares $240,058.00 +810.0%N/A3.5 $26.38
11/30/20211,000 shares $25,470.00 -23.1%N/A0.4 $25.47
11/15/20211,300 shares $35,100.00 +44.4%N/A0.3 $27.00
10/29/2021900 shares $23,607.00 -18.2%N/A0.2 $26.23
10/15/20211,100 shares $28,457.00 -15.4%N/A0.2 $25.87
9/30/20211,300 shares $33,527.00 -51.9%N/A0.3 $25.79
9/15/20212,700 shares $69,741.00 -30.8%N/A0.6 $25.83
8/31/20213,900 shares $104,052.00 +11.4%N/A0.8 $26.68
8/13/20213,500 shares $93,345.00 +9.4%N/A1.6 $26.67
7/30/20213,200 shares $84,448.00 +18.5%N/A1.5 $26.39
7/15/20212,700 shares $69,390.00 -20.6%N/A1 $25.70
6/30/20213,400 shares $87,992.00 -71.2%N/A0.9 $25.88
6/15/202111,800 shares $307,626.00 +35.6%N/A1.8 $26.07
5/28/20218,700 shares $224,439.12 -3.3%N/A1.1 $25.80
5/14/20219,000 shares $231,318.00 +20.0%N/A0.8 $25.70
4/30/20217,500 shares $195,210.00 -40.5%N/A0.6 $26.03
4/15/202112,600 shares $324,387.00 -44.0%N/A1 $25.75
3/31/202122,500 shares $566,775.00 -12.5%N/A1.7 $25.19
3/15/202125,700 shares $675,653.00 +30.5%N/A2.1 $26.29
2/26/202119,700 shares $516,140.00 -21.2%N/A1.9 $26.20
2/12/202125,000 shares $668,625.00 -3.9%N/A3.2 $26.75
1/29/202126,000 shares $690,300.00 +10.2%N/A2.9 $26.55
1/15/202123,600 shares $634,604.00 No ChangeN/A2.7 $26.89
1/15/2020100 shares $2,416.00 -50.0%N/A0 $24.16
12/31/2019200 shares $4,666.00 No ChangeN/A0.1 $23.33

FTXH Short Interest - Frequently Asked Questions

What is First Trust Nasdaq Pharmaceuticals ETF's current short interest?

Short interest is the volume of First Trust Nasdaq Pharmaceuticals ETF shares that have been sold short but have not yet been closed out or covered. As of November 30th, investors have sold 200 shares of FTXH short. Learn More on First Trust Nasdaq Pharmaceuticals ETF's current short interest.

Is First Trust Nasdaq Pharmaceuticals ETF's short interest increasing or decreasing?

First Trust Nasdaq Pharmaceuticals ETF saw a decrease in short interest during the month of November. As of November 30th, there was short interest totaling 200 shares, a decrease of 81.8% from the previous total of 1,100 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does First Trust Nasdaq Pharmaceuticals ETF's short interest compare to its competitors?

Here is how the short interest of companies compare to First Trust Nasdaq Pharmaceuticals ETF: JPMorgan Healthcare Leaders ETF (0.08%), ProShares UltraShort Nasdaq Biotechnology (3.82%), Invesco Nasdaq Biotechnology ETF (0.05%), ProShares Ultra Nasdaq Biotechnology (0.30%), Invesco Dorsey Wright Healthcare Momentum ETF (0.03%), VanEck Biotech ETF (0.89%), VanEck Pharmaceutical ETF (35.32%), and iShares Biotechnology ETF (22.30%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short First Trust Nasdaq Pharmaceuticals ETF stock?

Short selling FTXH is an investing strategy that aims to generate trading profit from First Trust Nasdaq Pharmaceuticals ETF as its price is falling. FTXH shares are trading up $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against First Trust Nasdaq Pharmaceuticals ETF?

A short squeeze for First Trust Nasdaq Pharmaceuticals ETF occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FTXH, which in turn drives the price of the stock up even further.

How often is First Trust Nasdaq Pharmaceuticals ETF's short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FTXH, twice per month. The most recent reporting period available is November, 30 2024.



Related Companies
Short Interest Tools

This page (NASDAQ:FTXH) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners
Trump’s Secret Manhattan Project
On January 20, a whole new Manhattan Project is set to begin: Trump’s Manhattan Project. Folks, I just s...
Banyan Hill Publishing | Sponsored
Is Starlink Set For The Largest IPO In History?
He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...
Paradigm Press | Sponsored
The #1 Crypto for AI
We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...
Weiss Ratings | Sponsored
Trump’s Sending THIS Crypto Higher on Purpose
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
Crypto 101 Media | Sponsored
Seeing is believing…
Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...
Porter & Company | Sponsored
Uncover the Top Gold Stock of the Bull Market
Gold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?
Huge Alerts | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
It’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...
Crypto Swap Profits | Sponsored
Please don’t take this warning lightly…
Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...
InvestorPlace | Sponsored